Atypical diabetic ketoacidosis: Case report

Balkan Medical Journal

Volumn 32, Issue 1, 2015, Pages 124-126

  Demirci, Hüseyin ^a   Coşar, Ramazan ^b   Çiftçi, Özcan ^b   Sarı, Işılay Kalan ^b  

^a TURGUT OZAL UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Cannabinoids; Diabetic ketoacidosis; Hypokalaemia

Indexed keywords

BONZAI; CANNABINOID; CANNABIS; GLUCOSE; INSULIN; POTASSIUM; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHOSCOPY; CANNABIS USE; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DEHYDRATION; DIABETIC KETOACIDOSIS; DYSPNEA; ELECTROCARDIOGRAM; EMERGENCY WARD; FLUID THERAPY; GRANULATION TISSUE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; INCENSE; INTENSIVE CARE UNIT; LABORATORY TEST; LEUKOCYTE COUNT; LUNG EDEMA; LUNG HEMORRHAGE; MALE; MEDICAL HISTORY; METABOLIC ACIDOSIS; RESPIRATORY DISTRESS; SINUS TACHYCARDIA; SYMPTOM; WHEEZING;

EID: 84922858352     PISSN: 21463123     EISSN: 21463131     Source Type: Journal    
DOI: 10.5152/balkanmedj.2015.15123     Document Type: Article

References (10)

1. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009;32:1335-1343.[CrossRef]
2. Hermanns-Clausen M, Kneisel S, Hutter M, Szabo B, Auwarter V. Acute intoxication by synthetic cannabinoids - Four case reports. Drug Test Anal 2013;5:790-794.[CrossRef]
3. Seely KA, Prather PL, James LP, Moran JH. Marijuana-based drugs: innovative therapeutics or designer drugs of abuse? Mol Interv 2011;11:36-51.[CrossRef]
4. Beuck S, Möller I, Thomas A, Klose A, Schlörer N, Schanzer W, et al. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing. Anal Bioanal Chem 2011;401:493-505.[CrossRef]
5. Hudson S, Ramsey J. The emergence and analysis of synthetic cannabinoids. Drug Test Anal 2011;3:466-478.[CrossRef]
6. Fattore L, Fratta W. Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci 2011;5:60.[CrossRef]
7. Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M. The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 2005;40:2-14.[CrossRef]
8. Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid exposures reported to Texas poison centers. J Addict Dis 2011;30:351-358.[CrossRef]
9. Simmons J, Cookman L, Kang C, Skinner C. Three cases of “spice” exposure. Clinical Toxicol (Phila) 2011;49:431-433.[CrossRef]
10. Loschner A, Cihla A, Jalali F, Ghamande S. Diffuse alveolar hemorrhage: add “greenhouse effect” to the growing list. CHEST Journal 2011;140:149A.[CrossRef]